Flexible workflows
Modify workflows, reviewer assignments, timelines, and approval paths without extensive configuration projects.
Read the article →
Emerging biotech and mid-sized pharma teams are seeking flexible, AI-powered alternatives that reduce review timelines, lower operational costs, and improve compliance. ERMA Evaluate™ was built for the realities of modern MLR review.
Many traditional MLR platforms were built for a different era of pharmaceutical marketing. As content volumes increase and regulatory expectations evolve, organizations often run into the same obstacles.
Today's life sciences organizations require more than workflow management.
Modify workflows, reviewer assignments, timelines, and approval paths without extensive configuration projects.
Implementations should take weeks — not months — and begin delivering value immediately.
Identify claims, match references, surface regulatory risks, highlight unsupported statements, and recommend reviewers automatically.
Enterprise-grade functionality without enterprise-level pricing, with predictable costs that scale alongside growth.
Organizations are moving away from rigid legacy systems toward solutions that adapt to evolving regulations and growing business requirements. ERMA combines AI-powered claims identification, automated reference assignment, regulatory intelligence, configurable workflows, and rapid implementation in a single platform.
A general comparison of AI-native review against traditional promotional review platforms.
| ERMA Evaluate | Legacy MLR platforms | |
|---|---|---|
| Claim identification | AI, no library | Manual library |
| Review routing | Flexible, non-linear | Rigid templates |
| FDA validation & Form 2253 | Included | Add-on / manual |
| Deployment | Works alongside existing systems | Often rip-and-replace |
Comparison reflects general differences between AI-native and traditional platforms; capabilities vary by vendor and configuration.
Yes. ERMA Evaluate is an AI-native MLR platform that teams adopt as an alternative to, or alongside, legacy promotional review systems.
Yes. ERMA integrates with legacy platforms via APIs and connectors, so you can add AI claim identification and FDA validation without a full migration.
No. ERMA is designed to enhance existing infrastructure. Many teams run it alongside their current system before consolidating.
ERMA identifies claims dynamically with AI rather than relying on a manual claims library, and offers flexible, non-linear routing instead of rigid templates.
Modern MLR platforms should deploy in weeks, not months. ERMA is built for rapid implementation so teams begin delivering value immediately rather than running lengthy configuration projects.
Real solutions for real MLR challenges